Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tranylcypromine in narcolepsy

H B Gernaat1, P M Haffmans, H Knegtering

  • 1Department of Biological Psychiatry, Bloemendaal Psychiatric Center, The Hague, Netherlands.

Pharmacopsychiatry
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Psychiatrische diagnostiek anno 2025].

Tijdschrift voor psychiatrie·2025
Same author

[The history of psychiatric diagnostic concepts].

Tijdschrift voor psychiatrie·2025
Same author

Psychedelics as a potential treatment for tobacco use disorder: a systematic review.

Discover mental health·2024
Same author

[Muscarinic M1 and/or M4 receptor agonists as potential novel treatments for psychoses].

Tijdschrift voor psychiatrie·2023
Same author

Cultural competence of mental health practitioners in the Netherlands.

The International journal of social psychiatry·2023
Same author

[The influence of maternal choline supplementation on fetal brain development and the risk of psychotic symptoms].

Tijdschrift voor psychiatrie·2023

Tranylcypromine may alleviate narcolepsy symptoms like hallucinations and sleep paralysis. This study observed significant improvements in a patient with severe narcolepsy, warranting further investigation into this treatment.

Area of Science:

  • Neurology
  • Sleep Medicine

Background:

  • Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness, cataplexy, hallucinations, and sleep paralysis.
  • Limited data exists on the efficacy of tranylcypromine for managing narcolepsy symptoms.

Observation:

  • A patient with severe narcolepsy was treated with tranylcypromine.
  • The study monitored the patient's response to the medication, focusing on specific narcolepsy symptoms and sleep characteristics.

Findings:

  • Tranylcypromine administration resulted in the complete resolution of hallucinations, nightmares, and sleep paralysis.
  • The treatment also led to a considerable reduction in cataplexy and improved daytime alertness.
  • Key physiological markers, including muscle atonia and cortical activity during REM sleep, remained unchanged.

Related Experiment Videos

Implications:

  • Tranylcypromine shows potential as an effective treatment for specific narcolepsy symptoms.
  • Further clinical studies are recommended to validate these findings and explore tranylcypromine's therapeutic role in narcolepsy management.